The table below shows REPLIGEN CORP's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$117.42M
$175.39M
$113.92M
$172.08M
$119.02M
$62.63M
Capital expenditure
$23.52M
$25.68M
$36.22M
$84.83M
$67.09M
$22.45M
Investing cash flow
-$298.47M
-$86.38M
-$123.28M
-$233.24M
-$221.17M
-$201.38M
Dividends paid
-
-
-
-
-
RGEN operating cash flow (10-K history)
REPLIGEN CORP reported operating cash flow of $117.42M for fiscal year 2025. That is down 33.1% from $175.39M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $7.52M (FY 2016) to $117.42M. Figures come from the company's audited annual reports as filed with the SEC.
